ClinicalTrials.govpublic full text
A Study to Evaluate the Efficacy and Safety of Pemigatinib Versus Chemotherapy in Unresectable or Metastatic Cholangiocarcinoma
unresectable cholangiocarcinoma, metastatic cholangiocarcinoma, cholangiocarcinoma, fibroblast growth factor receptor inhibitor, fgfr, fgfr rearrangement, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 884994
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.